Related Experiment Video
Updated: Jun 22, 2026
07:35
Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice
Published on: January 26, 2024
Hypoglycemia in athletes with diabetes
1Division of Endocrinology, University of Virginia Health System, PO Box 800136, McKim Hall, Room 4012, Charlottesville, VA 22808, USA. sek4b@virginia.edu
Clinics in Sports Medicine
|June 10, 2009
Summary
Exercise is crucial for managing diabetes but increases hypoglycemia risk. This review addresses exercise in type 1 diabetes and athletic activity, with principles applicable to type 2 diabetes management.
Area of Science:
- Endocrinology
- Sports Medicine
- Metabolic Disorders
Background:
- Exercise is a cornerstone therapy for type 1 and type 2 diabetes.
- A significant challenge in diabetes management is the risk of hypoglycemia.
- Increased glucose utilization during physical activity can precipitate hypoglycemia.
Purpose of the Study:
- To review the challenges and considerations of exercise in individuals with type 1 diabetes.
- To provide insights applicable to managing athletic activity in type 2 diabetes.
- To highlight the balance between exercise benefits and hypoglycemia risks.
Main Methods:
- Literature review focusing on exercise and athletic activity in type 1 diabetes.
- Discussion of physiological responses to exercise in diabetic populations.
- Synthesis of current understanding of hypoglycemia management during physical activity.
Main Results:
- Exercise significantly impacts glucose metabolism in diabetic individuals.
- Athletic activity presents unique challenges for glycemic control.
- Understanding glucose utilization is key to preventing exercise-induced hypoglycemia.
Conclusions:
- Careful management is essential for individuals with type 1 diabetes engaging in athletic activities.
- Strategies to mitigate hypoglycemia risk during exercise are critical.
- The principles discussed offer guidance for both type 1 and type 2 diabetes management during physical activity.
More Related Videos
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...